SEARCH WITHIN CONTENT
VOLUME 12 , ISSUE 3 ( September-December, 2019 ) > List of Articles
Miguel A Bergero, Patricio A Garcia Marchiñena, Guillermo Gueglio, Carlos David, Fernando Dipatto, Alberto Jurado
Citation Information : Bergero MA, Marchiñena PA, Gueglio G, David C, Dipatto F, Jurado A. Laparoscopic Ureterolysis without Omentoplasty in the Management of the Uropathy Secondary to Idiopathic Retroperitoneal Fibrosis. World J Lap Surg 2019; 12 (3):126-129.
License: CC BY-NC 4.0
Published Online: 12-01-2020
Copyright Statement: Copyright © 2019; The Author(s).
Introduction: Obstructive uropathy (OU) secondary to idiopathic retroperitoneal fibrosis (IRF) is an infrequent disease, and the standard treatment has not been established. However, ureterolysis with ureteral intraperitonealization is an effective therapeutic alternative. We present the successful management of OU secondary to an IRF by laparoscopic ureterolysis without omentoplasty (LUWO). Materials and methods: A retrospective descriptive study of 5 patients with IRF treated with LUWO was performed. Results: The average age was 60.4 years. The average creatinine was 3.86 mg/dL. There were no intraoperative or major postoperative complications. In a follow-up period of 31.2 months, all patients are asymptomatic, with an average creatinine level of 1.52 without dialysis requirement. No patients required corticosteroid therapy after surgery. Conclusion: Laparoscopic ureterolysis without omentoplasty is a safe and feasible option to treat the OU caused by IRF that provides good results in the medium-term follow-up, as we describe it in our series of cases.
© Jaypee Brothers Medical Publishers (P) LTD.